Swati Pathak in Davenport, Florida

Home Florida Davenport

Swati Pathak has Hematology/oncology as her primary medical specialty. Their primary office is: 40215 Hwy 27 in Davenport, Florida. There is an additional office location, for a total of two, for Swati Pathak that can be viewed further down.

They're a part of the: Florida Cancer Specialists And Research Institute, Llc medical group which has around 380 members. You can call their office at 863-421-9705 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2003 (around 21 years of experience). They are listed as doing telehealth appointments.

Swati Pathak Office Phone and Directions

Swati Pathak
Florida Cancer Specialists And Research Institute, Llc
40215 Hwy 27
Davenport, Florida 33837
863-421-9705

Patient Ratings
Please rate your experience with Swati Pathak below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 863-421-9705

Enter a starting address:

Healthcare Info for Swati Pathak

Medical School: Sorry, her university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Swati Pathak is listed as: Hematology/oncology
Approximate Years of Experience: 21
PAC (PECOS ID)#: 6002033917
NPI #: 1407012602
NPI Created On: 08/06/2008
NPI Last Updated Listed as: 06/15/2020
Primary Taxonomy Code: 207RH0000X
License Number:
ME145648
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Spanish, Hindi.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Blood test, comprehensive group of blood chemicals
Cyanocobalamin (vitamin b-12) level
Ferritin (blood protein) level
Folic acid level
Iron level
Lactate dehydrogenase (enzyme) level
Transferrin (iron binding protein) level
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788197149

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788197147

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788197151

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788197153

Being Disputed:: No

Product Related: No

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788197155

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $31

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799852549

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017553

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017555

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781017557

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 828520947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Genetic Disease

Name of Drug #1: GIVLAARI

Open Associated Drug #1: 71336-1001-1

Additional Office Locations

1. Florida Cancer Specialists And Research Institute, Llc
2 State Rd 60
Lake Wales, FL 33853
Florida Cancer Specialists
Group Members: 380

Phone: 863-421-9705

Enter a starting address:

Providers in Florida Cancer Specialists And Research Institute, Llc

1.Patrick Acevedo Md

1503 Buenos Aires Blvd
The Villages Fl 32159-6823
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

2.Patrick Acevedo Md

6420 W Newberry Rd E Wing
Gainesville Fl 32605-4308
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

3.Patrick Acevedo Md

1396 Whisper Cir
Sebring Fl 33870-1204
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

4.Patrick Acevedo Md

2848 Ctr Pointe Dr
Fort Myers Fl 33916-9521
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

5.Patrick Acevedo Md

901 Tamiami Trl S
Venice Fl 34285-3668
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

6.Patrick Acevedo Md

2231 Hwy 44 West 203
Inverness Fl 34453-3879
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

View all 380 members of Florida Cancer Specialists And Research Institute, Llc medical group